Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santonika is a Lithuania-based pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) specializing in the production of sterile and non-sterile dosage forms. The company provides a range of services including aseptic filling of ampoules and vials, terminal sterilization, and the manufacture of eye drops, ointments, and oral solids. Originally part of the Sanitas Group, Santonika operates a GMP-certified facility in Kaunas and serves international markets. In 2016, the company was acquired by the Polish pharmaceutical group Adamed, integrating it into a larger European healthcare network. Santonika focuses on high-quality manufacturing standards to support both proprietary product lines and third-party contract manufacturing. Its capabilities include full-cycle production from development and pilot batches to commercial-scale manufacturing and packaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santonika.